{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:51:55Z","timestamp":1788367915881,"version":"build-2803163510"},"reference-count":48,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["10067737"],"award-info":[{"award-number":["10067737"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Drug-induced phospholipidosis (PL) is a storage disorder caused by the formation of phospholipid-drug complexes in lysosomes. Because of the diversity of PL between species, human cell-based assays have been used to predict drug-induced PL in humans. We established three-dimensional (3D) human liver organoids as described previously and investigated their liver characteristics through multiple analyses. Drug-induced PL was initiated in these organoids and in monolayer HepG2 cultures, and cellular changes were systemically examined. Organoids that underwent differentiation showed characteristics of hepatocytes rather than HepG2 cells. The organoids also survived under PL-inducing drug conditions for 48 h and maintained a more stable albumin secretion level than the HepG2 cells. More cytoplasmic vacuoles were observed in organoids and HepG2 cells treated with more potent PL-induced drugs, but to a greater extent in organoids than in HepG2 cells. Lysosome-associated membrane protein 2, a marker of lysosome membranes, showed a stronger immunohistochemical signal in the organoids. PL-distinctive lamellar bodies were observed only in amiodarone-treated organoids by transmission electron microscopy. Human liver organoids are thus more sensitive to drug-induced PL and less affected by cytotoxicity than HepG2 cells. Since PL is a chronic condition, these results indicate that organoids better reflect metabolite-mediated hepatotoxicity in vivo and could be a valuable system for evaluating the phospholipidogenic effects of different compounds during drug development.<\/jats:p>","DOI":"10.3390\/ijms21082982","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T10:46:22Z","timestamp":1587638782000},"page":"2982","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Use of 3D Human Liver Organoids to Predict Drug-Induced Phospholipidosis"],"prefix":"10.3390","volume":"21","author":[{"given":"Ji-Young","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jeong","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Joon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ho","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Byul","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0002-6158","authenticated-orcid":false,"given":"Ju-Hyung","family":"Seok","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Seon","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Chan","family":"Son","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.etp.2012.11.008","article-title":"Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice","volume":"65","author":"Asaoka","year":"2013","journal-title":"Exp. Toxicol. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0006-2952(87)90415-1","article-title":"Influence of cationic amphiphilic drugs on the phosphatidylcholine hydrolysis by phospholipase A2","volume":"36","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic Amphiphilic Drug-Induced Phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: Are there functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp. Biol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jps.20792","article-title":"Lysosomal Sequestration of Amine-Containing Drugs: Analysis and Therapeutic Implications","volume":"96","author":"Kaufmann","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lenz, B., Braendli-Baiocco, A., Engelhardt, J., Fant, P., Fischer, H., Francke, S., Fukuda, R., Groters, S., Harada, T., and Harleman, H. (2018). Characterizing Adversity of Lysosomal Accumulation in Nonclinical Toxicity Studies: Results from the 5th ESTP International Expert Workshop, SAGE Publications Sage CA.","DOI":"10.1177\/0192623317749452"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","article-title":"Drug-induced phospholipidosis: Issues and future directions","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/0006-2952(90)90078-Y","article-title":"Aminoglycoside-induced renal phospholipidosis and nephrotoxicity","volume":"40","author":"Laurent","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00005072-196301000-00003","article-title":"Studies in Tay-Sachs disease. II. Ultrastructure of the cerebrum","volume":"22","author":"Terry","year":"1963","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_10","first-page":"155","article-title":"Fine structure and histochemistry of peripheral blood cells in Niemann-Pick disease","volume":"17","author":"Lazarus","year":"1967","journal-title":"Lab. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-104-3-348","article-title":"Amiodarone hepatotoxicity: A clinicopathologic study of five patients","volume":"104","author":"Rigas","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/jcp.40.4.418","article-title":"Granular cells as a marker of early amiodarone hepatotoxicity: A pathological and analytical study","volume":"40","author":"Shepherd","year":"1987","journal-title":"J. Clin. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1016\/j.bmcl.2013.06.034","article-title":"Are hERG channel blockers also phospholipidosis inducers?","volume":"23","author":"Sun","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00204-017-1995-9","article-title":"Why are most phospholipidosis inducers also hERG blockers?","volume":"91","author":"Slavov","year":"2017","journal-title":"Arch. Toxicol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-4274(90)90067-V","article-title":"Pathogenic factors in aminoglycoside-induced nephrotoxicity","volume":"51","author":"Kacew","year":"1990","journal-title":"Toxicol. Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: Nephrotoxicity","volume":"43","author":"Tulkens","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","first-page":"6265853","article-title":"A Mechanistic Study on the Amiodarone-Induced Pulmonary Toxicity","volume":"2016","author":"Khalifa","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_18","first-page":"774","article-title":"Amiodarone pulmonary toxicity: Biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects","volume":"244","author":"Martin","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archopht.1981.03930010259007","article-title":"Amiodarone keratopathy: Drug-induced lipid storage disease","volume":"99","author":"Kenyon","year":"1981","journal-title":"Arch. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/brain\/108.3.753","article-title":"The pathology of amiodarone neurotoxicity: II. Peripheral neuropathy in man","volume":"108","author":"Jacobs","year":"1985","journal-title":"Brain"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/1523-1747.ep12277571","article-title":"Photosensitivity and Hyperpigmentation in Amiodarone-Treated Patients: Incidence, Time Course, and Recovery","volume":"93","author":"Rappersberger","year":"1989","journal-title":"J. Investig. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840080326","article-title":"Amiodarone-induced hepatic phospholipidosis: Correlation of morphological and biochemical findings in an animal model","volume":"8","author":"Pirovino","year":"1988","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/toxsci\/kfu132","article-title":"Glucosylceramide and Lysophosphatidylcholines as Potential Blood Biomarkers for Drug-Induced Hepatic Phospholipidosis","volume":"141","author":"Saito","year":"2014","journal-title":"Toxicol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1194\/jlr.M073395","article-title":"Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease","volume":"58","author":"Lecommandeur","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0192623309352496","article-title":"A Strategy for Risk Management of Drug-Induced Phospholipidosis","volume":"37","author":"Chatman","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.tiv.2011.06.017","article-title":"Evaluation and validation of multiple cell lines and primary mouse macrophages to predict phospholipidosis potential","volume":"25","author":"Lecureux","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/adt.2007.119","article-title":"Phospholipidosis Assay in HepG2 Cells and Rat or Rhesus Hepatocytes Using Phospholipid Probe NBD-PE","volume":"6","author":"Bhandari","year":"2008","journal-title":"Assay Drug Dev. Technol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/1087057113502851","article-title":"Detection of phospholipidosis induction: A cell-based assay in high-throughput and high-content format","volume":"19","author":"Shahane","year":"2013","journal-title":"J. Biomol. Screen."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.tiv.2011.05.026","article-title":"High content screening analysis of phospholipidosis: Validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis","volume":"25","author":"Havinga","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/nprot.2016.097","article-title":"Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation","volume":"11","author":"Broutier","year":"2016","journal-title":"Nat. Protoc."},{"key":"ref_31","first-page":"1","article-title":"Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine","volume":"7","author":"Xu","year":"2018","journal-title":"Exp. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1517\/17425251003674356","article-title":"Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity","volume":"6","author":"Meng","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2013.01.012","article-title":"A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity","volume":"268","author":"Kostadinova","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2174\/138920012802850001","article-title":"Drug-induced liver steatosis and phospholipidosis: Cell-based assays for early screening of drug candidates","volume":"13","author":"Donato","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfm157","article-title":"In Vitro Detection of Drug-Induced Phospholipidosis Using Gene Expression and Fluorescent Phospholipid Based Methodologies","volume":"99","author":"Nioi","year":"2007","journal-title":"Toxicol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfh264","article-title":"A Toxicogenomic Approach to Drug-Induced Phospholipidosis: Analysis of Its Induction Mechanism and Establishment of a Novel in Vitro Screening System","volume":"83","author":"Sawada","year":"2004","journal-title":"Toxicol. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/17425251003601961","article-title":"Bis (monoacylglycerol) phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities","volume":"6","author":"Tengstrand","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1293\/tox.21.9","article-title":"Drug-induced Phospholipidosis -Pathological Aspects and Its Prediction","volume":"21","author":"Nonoyama","year":"2008","journal-title":"J. Toxicol. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/sj.bjp.0707611","article-title":"Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures","volume":"153","author":"Shen","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cbi.2006.05.005","article-title":"Acetaminophen-induced hepatotoxicity of gel entrapped rat hepatocytes in hollow fibers","volume":"162","author":"Shen","year":"2006","journal-title":"Chem. Interact."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2131\/jts.31.23","article-title":"In vivo hepatotoxicity study of rats in comparison with in vitro hepatotoxicity screening system","volume":"31","author":"Kikkawa","year":"2006","journal-title":"J. Toxicol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cbi.2004.09.003","article-title":"Human and animal hepatocytes in vitro with extrapolation in vivo","volume":"150","author":"Chan","year":"2004","journal-title":"Chem. Interact."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid Modeling of the Tumor Immune Microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1038\/s41598-019-45514-3","article-title":"Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells","volume":"9","author":"Pettinato","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Farrell, R.E. (2010). Chapter 2\u2014RNA Isolation Strategies. RNA Methodologies, Academic Press. [4th ed.].","DOI":"10.1016\/B978-0-12-374727-3.00002-4"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/1091581817726040","article-title":"An Immunohistochemical Investigation of Renal Phospholipidosis and Toxicity in Rats","volume":"36","author":"Ma","year":"2017","journal-title":"Int. J. Toxicol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/01926230701481956","article-title":"An Immunohistochemical Approach to Differentiate Hepatic Lipidosis from Hepatic Phospholipidosis in Rats","volume":"35","author":"Obert","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2045-3701-1-10","article-title":"Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: Possible implications of lysosomal dysfunction in macular degeneration","volume":"1","author":"Chen","year":"2011","journal-title":"Cell Biosci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/8\/2982\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:09:08Z","timestamp":1760364548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/8\/2982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["ijms21082982"],"URL":"https:\/\/doi.org\/10.3390\/ijms21082982","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]}}}